APA (7th ed.) Citation

Case, B. C., Torguson, R., Zhang, C., & Waksman, R. (2021). Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia. Cardiovascular Revascularization Medicine, 33, 55. https://doi.org/10.1016/j.carrev.2021.06.016

Chicago Style (17th ed.) Citation

Case, Brian C., Rebecca Torguson, Cheng Zhang, and Ron Waksman. "Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia." Cardiovascular Revascularization Medicine 33 (2021): 55. https://doi.org/10.1016/j.carrev.2021.06.016.

MLA (9th ed.) Citation

Case, Brian C., et al. "Overview of the Virtual 2021 FDA's Circulatory System Devices Advisory Panel on Lutonix 014 Drug-Coated Percutaneous Transluminal Angioplasty Catheter for Below-the-Knee Lesions in Critical Limb Ischemia." Cardiovascular Revascularization Medicine, vol. 33, 2021, p. 55, https://doi.org/10.1016/j.carrev.2021.06.016.